Related content

Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Phase I Study

By Derks Michael   Anzures-Cabrera Judith   Turnbull Lynn   Phelan Mary  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite

Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

By Hasler Felix   Grimberg Ulrike   Benz Marco   Huber Theo   Vollenweider Franz  

Psychopharmacology, Vol. 172, Iss. 2, 2004-03 ,pp. : 145-156

Springer Publishing Company

Access to resources Recommend Favorite

Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects: A Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Study

By Peeters Pierre A.M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 867-874

Adis International

Access to resources Recommend Favorite

Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects: A Randomized, Crossover, Double-Blind versus Placebo, Moxifloxacin-Controlled Study

By >   >   Dionisio Paolo  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 5-14

Adis International

Access to resources Recommend Favorite

Pantoprazole Does Not Affect Performance in Traffic-Related Safety Tests: A Double-Blind, Randomised, Placebo-Controlled, Crossover Study in Healthy Volunteers

By Herberg K-W.  

Clinical Drug Investigation, Vol. 16, Iss. 1, 1998-07 ,pp. : 63-70

Adis International

Access to resources Recommend Favorite